Richard Tarlowe

Apr 15, 2024 | lexblog.com | Andrew J. Ehrlich |Gregory F. Laufer |Jessica Carey |Richard Tarlowe

On Friday, April 5, 2024, a jury in the Northern District of California found that the SEC had established that Defendant Matthew Panuwat, a former senior director of business development at biopharmaceutical firm Medivation, was liable under a civil misappropriation theory of insider trading for violations of Section 10(b) of the Exchange Act and SEC Rule 10b-5.

Sep 5, 2023 | lexblog.com | Lorin L. Reisner |Audra J. Soloway |Richard Tarlowe |Alexis K. Kaufman

On August 24, 2023, in a highly anticipated decision, the Second Circuit in Kirschner v. JPMorgan Chase Bank, N.A. et al.